search
Back to results

The Use of Prophylactic Antibiotics in Endoscopy Sinus Surgery for Chronic Rhinosinusitis With or Without Polyp

Primary Purpose

Chronic Sinus Infection

Status
Unknown status
Phase
Phase 4
Locations
Canada
Study Type
Interventional
Intervention
Amoxicillin / Clavulanic acid 875mg / 125mg
Placebos
Sponsored by
CHU de Quebec-Universite Laval
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Chronic Sinus Infection focused on measuring ESS, Prophylactic antibiotics, Chronic sinus infection

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • 18 years old and over able to consent
  • Patients with chronic rhinosinusitis and failure to maximal medical treatment
  • Endoscopic sinus surgery with at least one of the following: maxillary antrostomy, ethmoidectomy, sphenoidotomy and / or frontal sinusotomy

Exclusion Criteria:

  • Antibiotherapy less than 2 weeks before the intervention
  • Penicillin allergy
  • Inability to establish follow-up
  • Open sinus surgery or associated septorhinoplasty (simple septoplasty is not considered an exclusion criterion)
  • Immunodeficiency
  • Cystic fibrosis of the pancreas
  • Pregnancy
  • odontogenic sinusitis
  • Fungal sinusitis
  • Diabetic
  • Ciliary dyskinesia
  • Sinus neoplasia
  • Patient requiring antibiotic prophylaxis for endocarditis

Sites / Locations

  • Simon-Pierre Harvey-BolducRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Active Comparator

Placebo Comparator

Active Comparator

Placebo Comparator

Arm Label

Clavulin group with polyps

Placebo group with polyps

Clavulin group without polyps

Placebo group without polyps

Arm Description

Group who will receive clavulin after the endoscopic sinus surgery in prophylactic and who have polyps in the surgery

Group who will receive placebo after the endoscopic sinus surgery in prophylactic and who have polyps in the surgery

Group who will receive clavulin after the endoscopic sinus surgery in prophylactic and who haven't polyps in the surgery

Group who will receive clavulin after the endoscopic sinus surgery in prophylactic and who haven't polyps in the surgery

Outcomes

Primary Outcome Measures

Modified Lund-Kennedy endoscopic score
The modified Lund-Kennedy score is an endoscopic score that measures sinus involvement during endoscopy. It is divided into 2 nostrils. For each nostril, it has a score of 0 to 2 for the presence of polyp, edema and flow. The score is therefore 0 to 6 for each nostril for a maximum of 12. The higher the score, the more severe is the condition
Quality of life of patients SNOT-22
The SNOT-22 score is a quality of life score. It contains 22 sinus symptoms. Each of the symptoms is scored from 0 to 5, with 0 being no problem and 5 being a severe problem. The SNOT-22 is a score of 0 to 110, the higher the score, the more severe the disease.

Secondary Outcome Measures

Modified Lund-Kennedy endoscopic score
The modified Lund-Kennedy score is an endoscopic score that measures sinus involvement during endoscopy. It is divided into 2 nostrils. For each nostril, it has a score of 0 to 2 for the presence of polyp, edema and flow. The score is therefore 0 to 6 for each nostril for a maximum of 12. The higher the score, the more severe is the condition
Rate of infection
Evaluate the rate of infection after endoscopic sinus surgery with or without prophylactic antibiotics, defined according to the criteria of acute bacterial rhinosinusitis.
VAS symptoms
The visual analogue scale is a scale containing 6 rhinological symptoms. On a 10 centimeter scale, the patient will write the important of his symptoms, 10 being the maximum and 0 the minimum.
Side effects
Compare side effects when using prophylactic antibiotics after endoscopic sinus surgery for chronic rhinosinusitis versus placebo.
Modified Lund-Kennedy endoscopic score
The modified Lund-Kennedy score is an endoscopic score that measures sinus involvement during endoscopy. It is divided into 2 nostrils. For each nostril, it has a score of 0 to 2 for the presence of polyp, edema and flow. The score is therefore 0 to 6 for each nostril for a maximum of 12. The higher the score, the more severe is the condition
Quality of life of patients SNOT-22
The SNOT-22 score is a quality of life score. It contains 22 sinus symptoms. Each of the symptoms is scored from 0 to 5, with 0 being no problem and 5 being a severe problem. The SNOT-22 is a score of 0 to 110, the higher the score, the more severe the disease.
Quality of life of patients SNOT-22
The SNOT-22 score is a quality of life score. It contains 22 sinus symptoms. Each of the symptoms is scored from 0 to 5, with 0 being no problem and 5 being a severe problem. The SNOT-22 is a score of 0 to 110, the higher the score, the more severe the disease.

Full Information

First Posted
January 15, 2019
Last Updated
July 13, 2020
Sponsor
CHU de Quebec-Universite Laval
search

1. Study Identification

Unique Protocol Identification Number
NCT03809312
Brief Title
The Use of Prophylactic Antibiotics in Endoscopy Sinus Surgery for Chronic Rhinosinusitis With or Without Polyp
Official Title
The Use of Prophylactic Antibiotics in Endoscopy Sinus Surgery for Chronic Rhinosinusitis With or Without Polyp: A Randomized, Double-blind Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
July 2020
Overall Recruitment Status
Unknown status
Study Start Date
August 14, 2019 (Actual)
Primary Completion Date
December 2020 (Anticipated)
Study Completion Date
February 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
CHU de Quebec-Universite Laval

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This is a randomized, double-blind clinical trial on the prophylactic use of antibiotics in postoperative endoscopic sinus vs placebo surgery. Patients with chronic rhinosinusitis with or without polyps who have consented to endoscopic sinus surgery according to Canadian practice guidelines may be included in the study after approval by the Research Ethics Board of the University Hospital Center. Quebec and signature of consent.
Detailed Description
The severity of the disease will be evaluated preoperatively according to the SNOT-22 score, the visual analogue scale of nasal symptoms, the Lund-Mackay score on the CT-scan and the Modified Lund-Kennedy endoscopic score (sinusoscopy will be recorded). Relevant demographics and medical history of participants will also be collected preoperatively. The extension of the CES and intraoperative findings will be noted. Patients who have an infection during the procedure (pus with positive culture) will be excluded from the study. During the surgery, 4 groups will be formed as described in the figure below. Patients will be divided according to the presence or absence of polyps at the endoscopy and randomized in one of the 2 groups by the pharmacy of the CHU of Quebec. This will provide either a prescription of Clavulin 875 mg per os twice daily for 10 days, or a placebo of similar visual appearance in the same dosage. A bioabsorbable dressing (NasoPore, Stryker) will be positioned at the mid-meatus level at the end of the procedure. Nasal irrigations of saline solution will be prescribed post-operatively (qid for 1 month) as well as intra-nasal corticosteroids bid after 1 week (usual treatment). The addition of systemic corticosteroids will be left to the judgment of the surgeon, noted and analyzed as a confounding factor. Follow-up will be done at 2 weeks, 1 month, 3 months and 6 months post-surgery. Patients will have to complete the SNOT-22 quality of life score and the visual similar scale of nasal symptoms at each visit. Sinusoscopy will be recorded at scheduled visits postoperatively. A single blind evaluator (to limit inter-rater differences) will analyze the video recordings to establish the modified Lund-Kennedy endoscopic score for each patient. Middle-meat secretion culture will be performed if pus is present during sinusoscopy and an antibiotic prescribed if needed. The patient will have to fill in a diary of other medications (analgesics, narcotics, anti-inflammatories) as well as a diary of side effects that will be collected at the visit of a post-operative month.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Sinus Infection
Keywords
ESS, Prophylactic antibiotics, Chronic sinus infection

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Model Description
During the surgery, 4 groups will be formed as described in the figure below. Patients will be divided according to the presence or absence of polyps at the endoscopy and randomized in one of the 2 groups by the pharmacy of the CHU of Quebec. This will give either a prescription of Clavulin 875 mg per os to be taken twice a day for 10 days, or a placebo of similar visual appearance according to the same dosage
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Masking Description
Randomisation by the pharmacy, no one in the investigator and the participant will know the intervention
Allocation
Randomized
Enrollment
134 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Clavulin group with polyps
Arm Type
Active Comparator
Arm Description
Group who will receive clavulin after the endoscopic sinus surgery in prophylactic and who have polyps in the surgery
Arm Title
Placebo group with polyps
Arm Type
Placebo Comparator
Arm Description
Group who will receive placebo after the endoscopic sinus surgery in prophylactic and who have polyps in the surgery
Arm Title
Clavulin group without polyps
Arm Type
Active Comparator
Arm Description
Group who will receive clavulin after the endoscopic sinus surgery in prophylactic and who haven't polyps in the surgery
Arm Title
Placebo group without polyps
Arm Type
Placebo Comparator
Arm Description
Group who will receive clavulin after the endoscopic sinus surgery in prophylactic and who haven't polyps in the surgery
Intervention Type
Drug
Intervention Name(s)
Amoxicillin / Clavulanic acid 875mg / 125mg
Intervention Description
Amoxicillin / Clavulanic acid 875 mg / 125 mg BID x 10 days
Intervention Type
Drug
Intervention Name(s)
Placebos
Intervention Description
Placebos BID x 10 days
Primary Outcome Measure Information:
Title
Modified Lund-Kennedy endoscopic score
Description
The modified Lund-Kennedy score is an endoscopic score that measures sinus involvement during endoscopy. It is divided into 2 nostrils. For each nostril, it has a score of 0 to 2 for the presence of polyp, edema and flow. The score is therefore 0 to 6 for each nostril for a maximum of 12. The higher the score, the more severe is the condition
Time Frame
3 months
Title
Quality of life of patients SNOT-22
Description
The SNOT-22 score is a quality of life score. It contains 22 sinus symptoms. Each of the symptoms is scored from 0 to 5, with 0 being no problem and 5 being a severe problem. The SNOT-22 is a score of 0 to 110, the higher the score, the more severe the disease.
Time Frame
3 months
Secondary Outcome Measure Information:
Title
Modified Lund-Kennedy endoscopic score
Description
The modified Lund-Kennedy score is an endoscopic score that measures sinus involvement during endoscopy. It is divided into 2 nostrils. For each nostril, it has a score of 0 to 2 for the presence of polyp, edema and flow. The score is therefore 0 to 6 for each nostril for a maximum of 12. The higher the score, the more severe is the condition
Time Frame
1 months
Title
Rate of infection
Description
Evaluate the rate of infection after endoscopic sinus surgery with or without prophylactic antibiotics, defined according to the criteria of acute bacterial rhinosinusitis.
Time Frame
3 months
Title
VAS symptoms
Description
The visual analogue scale is a scale containing 6 rhinological symptoms. On a 10 centimeter scale, the patient will write the important of his symptoms, 10 being the maximum and 0 the minimum.
Time Frame
3 months
Title
Side effects
Description
Compare side effects when using prophylactic antibiotics after endoscopic sinus surgery for chronic rhinosinusitis versus placebo.
Time Frame
3 months
Title
Modified Lund-Kennedy endoscopic score
Description
The modified Lund-Kennedy score is an endoscopic score that measures sinus involvement during endoscopy. It is divided into 2 nostrils. For each nostril, it has a score of 0 to 2 for the presence of polyp, edema and flow. The score is therefore 0 to 6 for each nostril for a maximum of 12. The higher the score, the more severe is the condition
Time Frame
6 months
Title
Quality of life of patients SNOT-22
Description
The SNOT-22 score is a quality of life score. It contains 22 sinus symptoms. Each of the symptoms is scored from 0 to 5, with 0 being no problem and 5 being a severe problem. The SNOT-22 is a score of 0 to 110, the higher the score, the more severe the disease.
Time Frame
1 months
Title
Quality of life of patients SNOT-22
Description
The SNOT-22 score is a quality of life score. It contains 22 sinus symptoms. Each of the symptoms is scored from 0 to 5, with 0 being no problem and 5 being a severe problem. The SNOT-22 is a score of 0 to 110, the higher the score, the more severe the disease.
Time Frame
6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 18 years old and over able to consent Patients with chronic rhinosinusitis and failure to maximal medical treatment Endoscopic sinus surgery with at least one of the following: maxillary antrostomy, ethmoidectomy, sphenoidotomy and / or frontal sinusotomy Exclusion Criteria: Antibiotherapy less than 2 weeks before the intervention Penicillin allergy Inability to establish follow-up Open sinus surgery or associated septorhinoplasty (simple septoplasty is not considered an exclusion criterion) Immunodeficiency Cystic fibrosis of the pancreas Pregnancy odontogenic sinusitis Fungal sinusitis Diabetic Ciliary dyskinesia Sinus neoplasia Patient requiring antibiotic prophylaxis for endocarditis
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Simon-Pierre Harvey-Bolduc, DR
Phone
418-455-6167
Email
simon-pierre.harvey-bolduc.1@ulaval.ca
First Name & Middle Initial & Last Name or Official Title & Degree
Marie-Noëlle Corriveau
Email
marie-noelle.corriveau@fmed.ulaval.ca
Facility Information:
Facility Name
Simon-Pierre Harvey-Bolduc
City
Québec
ZIP/Postal Code
G1H0C2
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Simon-Pierre Harvey-Bolduc, DR
Phone
418-455-6167
Email
simon-pierre.harvey-bolduc.1@ulaval.ca

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

The Use of Prophylactic Antibiotics in Endoscopy Sinus Surgery for Chronic Rhinosinusitis With or Without Polyp

We'll reach out to this number within 24 hrs